The National Community Pharmacists Association (NCPA) has expressed support for new federal reforms targeting pharmacy benefit manager (PBM) practices, which were signed into law by President Donald Trump. Read More »
U.S. Representative Raja Krishnamoorthi advocates for a bipartisan bill aimed at reforming pharmacy benefit manager practices that allegedly inflate drug prices. Read More »
Public health officials have announced that individuals may have been exposed to measles at several locations in Milbank and Brookings, South Dakota. Read More »
The Federal Trade Commission (FTC) has announced that Cigna’s Express Scripts will make significant changes to its business practices following a settlement aimed at addressing concerns over drug pricing and competition in the pharmacy sector. Read More »
Congressional bill H.R. 7148 has been signed into law by the White House, introducing reforms targeting pharmacy benefit manager practices in Medicare Part D. The legislation aims to shift compensation structures away from rebate-linked incentives... Read More »
Anthony DiGiorgio from UCSF highlights concerns regarding the financial impact of the 340B drug discount program on taxpayers and employer plans. Read More »
National Community Pharmacists Association CEO B. Douglas Hoey testified before the House Energy and Commerce Committee’s Subcommittee on Health, urging Congress to address what he described as harmful effects of consolidation among large pharmacy... Read More »
Dae Y. Lee called attention to a proposed Department of Labor rule that would require pharmacy benefit managers to reveal details about their revenue practices. He encouraged stakeholders to submit public comments before the March 31 deadline. State audits and legal actions have highlighted ongoing concerns over spread pricing and retroactive fees. Read More »
Fred Roeder from Consumer Choice Center analyzes challenges in the 340B Drug Discount Program. He highlights issues with post-dispensing eligibility checks and suggests a rebate model as a solution. Read More »
Mark Cuban says new rules targeting pharmacy benefit managers will not shift pricing power away from industry leaders controlling drug rebates. Recent reports highlight continued market dominance by three major PBMs despite regulatory efforts. Experts point to rebate structures as a key factor affecting patient costs. Read More »
Building America’s Future claims a lobbying group is blocking reforms aimed at increasing transparency in the federal drug discount program known as 340B. Read More »
U.S. Representative Gabe Evans said pharmacy benefit managers have contributed to rising prescription drug costs and highlighted recent congressional action aimed at reforming their practices. Read More »
The South Dakota Department of Health has announced the release of its first round of Requests for Proposals (RFPs) under the Rural Health Transformation initiative. Read More »
The Georgia State Board of Pharmacy has announced the adoption of Board Policy #9. Read More »
Molly Jenkins of PhRMA said increased scrutiny of the federal 340B drug pricing program highlights concerns about rising costs without clear patient benefits. Read More »
State officials in New Mexico have issued a mandatory recall of a medical cannabis edible after finding it exceeded the legal limit for THC content. Read More »
Alerts Sign-up
